Skip to main content
Tate & Lyle PLC logo

Tate & Lyle PLC — Investor Relations & Filings

Ticker · TATE ISIN · GB00BP92CJ43 LEI · 2138008K14474WPKZ244 IL Manufacturing
Open in API
Filings indexed 1,015 across all filing types
Latest filing 2019-05-31 Delisting Announcement
Country GB United Kingdom
Listing IL TATE

About Tate & Lyle PLC

https://www.tateandlyle.com/

Tate & Lyle PLC is a global provider of specialty ingredients and solutions for the food, beverage, and other industrial markets. The company focuses on creating high-value ingredients that meet consumer demand for healthier, tastier, and more sustainable products. Its core expertise lies in developing solutions for sugar and calorie reduction, texture and mouthfeel enhancement, and nutritional fortification, including fiber enrichment. Following its combination with CP Kelco, the company offers an expanded portfolio of ingredients. In addition to its primary food and beverage focus, Tate & Lyle provides readily biodegradable ingredients for personal care and home care applications, leveraging the science of food to help manufacturers innovate and reformulate their products.

Recent filings

Filing Released Lang Actions
Restoration - Totally Plc
Delisting Announcement Classification · 99% confidence The document is very short (1097 characters) and contains an RNS Number, a date (31 May 2019), and explicitly states 'Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 31/05/2019 7:30am, an announcement having been made and a document having been published.' This structure indicates an official regulatory announcement regarding a trading event, rather than the full content of a report. Since it is a general regulatory announcement distributed via RNS and doesn't fit specific categories like DIV, DIRS, or DLST (which is a specific type of suspension/delisting), the most appropriate general category is Regulatory Filings (RNS).
2019-05-31 English
Proposed acquisition of Greenbrook Healthcare
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement from Totally PLC dated May 31, 2019. It details a 'Proposed acquisition of Greenbrook Healthcare,' a 'Proposed placing' to raise capital, and a 'Notice of General Meeting.' Crucially, it mentions that because the transaction constitutes a reverse takeover under AIM Rules, the company has published an 'admission document' ('Admission Document') which will be posted to Shareholders and is available on the website. The text itself is an announcement describing these actions and referring to the main document (the Admission Document) that contains the full details required for the shareholder vote and listing restoration. Since this document is an announcement about the publication of a major document (the Admission Document) and involves capital raising and a significant corporate action requiring shareholder approval (General Meeting), it fits best under the category of a general regulatory announcement that details significant corporate actions, rather than being the full financial report (10-K, IR) or the proxy statement (DEF 14A/PSI) itself. Given the context of an RNS announcement detailing a major transaction and the publication of required documentation, the most appropriate classification is Regulatory Filings (RNS), as it is a broad regulatory disclosure about a significant event, or potentially Capital/Financing Update (CAP) due to the placing. However, the primary function here is the regulatory disclosure of the M&A and associated capital raise, which is being disseminated via RNS. Since the document explicitly states that the Admission Document (which would contain the detailed proxy/governance info) is being published separately, RNS is the best fit for this announcement wrapper.
2019-05-31 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of transaction by Person Discharging Managerial Responsibilities' and details the acquisition of shares by an executive (Imran Nawaz). It explicitly references compliance with the EU Market Abuse Regulation and is distributed via 'RNS Number : 5093A'. This structure and content directly correspond to insider trading reports, which are classified under Director's Dealing (DIRS) in the provided schema. Although it uses the RNS distribution service, the core subject matter is specific enough to warrant the DIRS classification over the general RNS fallback.
2019-05-29 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMR")'. It details specific share transactions (acquisitions/releases of awards) by company executives (Joan Braca, Jim Stutelberg) and is dated May 28, 2019. This content directly corresponds to insider trading reports or director's dealings, which are typically filed via regulatory news services. The definition for Director's Dealing (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although it is distributed via RNS, the core content is a DIRS filing. Given the specific nature of the content (PDMR transactions), DIRS is the most accurate classification over the general RNS fallback.
2019-05-28 English
Final Results
Earnings Release Classification · 99% confidence The document explicitly states 'TATE & LYLE PLC STATEMENT OF FULL YEAR RESULTS For the year ended 31 March 2019'. It contains detailed financial tables, key highlights, management commentary (CEO quote), and forward-looking statements typical of an annual financial disclosure. Although it is presented via an RNS announcement format (indicated by 'RNS Number : 9109Z'), the core content is the comprehensive 'Full Year Results' for the entire fiscal year, which aligns best with the Annual Report (10-K) definition, even if the 10-K filing itself is the formal SEC document. Given the comprehensive nature of the financial data covering the full year, it is classified as the Annual Report content. The document length is substantial (87,589 chars), confirming it is not just a brief announcement (RPA). FY 2019
2019-05-23 English
Statement re proposed acquisition
Delisting Announcement Classification · 99% confidence The document begins with an 'RNS Number' and is dated May 17, 2019. It explicitly states it contains 'inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR")'. The content discusses a 'proposed acquisition' (M&A activity) and the resulting 'suspension of share trading on AIM' due to the transaction constituting a 'reverse takeover under rule 14 of the AIM Rules'. While it relates to M&A (TAR) and capital changes (SHA), the primary function of this specific filing is to serve as an immediate, mandatory regulatory disclosure regarding a significant corporate event (suspension of trading pending a reverse takeover announcement). Since it is a general regulatory announcement disseminated via RNS and deals with a specific corporate action that doesn't fit perfectly into the M&A (TAR) or Capital (CAP/SHA) categories as a primary classification, and it is clearly identified as an RNS release, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2019-05-17 English

Browse filings by year

47 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.